NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation
NLRC3 inhibits inflammatory responses. Neuroinflammation induces and accelerates the onset of Alzheimer’s disease (AD). This study is aimed at investigating whether NLRC3 plays a role in neuroinflammation, Aβ accumulation, and neuroprotection in AD mice. 12-month-old APP/PS1 transgenic and C57 mice...
Gespeichert in:
| Veröffentlicht in: | Oxidative medicine and cellular longevity 2020, Vol.2020 (2020), p.1-14 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 14 |
|---|---|
| container_issue | 2020 |
| container_start_page | 1 |
| container_title | Oxidative medicine and cellular longevity |
| container_volume | 2020 |
| creator | Guo, Wen Zhou, Li Fang, Jian Yu, Zaixin Zha, Lihuang Zhou, Jun |
| description | NLRC3 inhibits inflammatory responses. Neuroinflammation induces and accelerates the onset of Alzheimer’s disease (AD). This study is aimed at investigating whether NLRC3 plays a role in neuroinflammation, Aβ accumulation, and neuroprotection in AD mice. 12-month-old APP/PS1 transgenic and C57 mice were used for studies in vivo. In vitro, organotypic hippocampal slices were cultured. We found that the expression of NLRC3 was downregulated in the brain tissues of APP/PS1 mice. Mice in the APP/PS1 group had a significant attenuation of learning and memory ability compared to the control group, and the ability was improved in APP/PS1 + LV-NLRC3 mice. The expressions of 6E10, GFAP, Iba1, and PI3K in the hippocampus and brains of APP/PS1 mice were significantly higher than those of the control group, while the expressions of NeuN were lower than that of the control group. With the overexpression of NLRC3 in the APP/PS1 + LV-NLRC3 group, the expressions of 6e10, GFAP, Iba1, and PI3K were significantly lower, while the expression of NeuN was significantly higher compared to the APP/PS1 group. NLRC3 colocalized with NeuN. PI3K activation with 740YP increased the expression of GFAP and Iba-1 in the hippocampus with the exogenous NLRC3 protein. We conclude that NLRC3 may play an important role in the development and progression of AD. Downregulation of NLRC3 can lead to the activation of PI3K, resulting in abnormal plaque deposition, glial cell activation, and neuron loss during AD. NLRC3 delays the progression of AD in APP/PS1 mice via inhibiting PI3K activation. |
| doi_str_mv | 10.1155/2020/5328031 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7775163</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2474848197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-973b26555e3e0a7d0de29033a345eecc4cd3925a5d9a606a0560ce23749527e43</originalsourceid><addsrcrecordid>eNqNkc1PGzEQxa2qVaGhN86VJY40ZOyxd-NLpSh8RQ2w0HK2HO8kMQq7YG-C-O9ZlDTAracZaX7z5mkeY_sCjoTQuidBQk-j7AOKT2xXGCW7YIz6vO0Bdti3lO4AMpRKfGU7iEpqCWaXXV-Ob4bIj2nhnhNv5sSLWM8ipRTqitdTPjjmoeKDougVfwS_CJ74Kjg-quZhEppQzXgxwt984Juwck27tMe-TN0i0fdN7bDb05O_w_Pu-OpsNByMu15hv-maHCcy01oTEri8hJKkAUSHShN5r3yJRmqnS-MyyBzoDDxJzJXRMieFHfZrrfuwnNxT6alqolvYhxjuXXy2tQv246QKczurVzbPcy0ybAUONgKxflxSauxdvYxV69lKlau-6ovWZIf9XFM-1ilFmm4vCLCvAdjXAOwmgBb_8d7VFv738RY4XAPzUJXuKfynHLUMTd0bLaH1h_gCi5iULg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2474848197</pqid></control><display><type>article</type><title>NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation</title><source>PubMed Central Open Access</source><source>Wiley Online Library Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Guo, Wen ; Zhou, Li ; Fang, Jian ; Yu, Zaixin ; Zha, Lihuang ; Zhou, Jun</creator><contributor>Ghosh, Rajeshwary ; Rajeshwary Ghosh</contributor><creatorcontrib>Guo, Wen ; Zhou, Li ; Fang, Jian ; Yu, Zaixin ; Zha, Lihuang ; Zhou, Jun ; Ghosh, Rajeshwary ; Rajeshwary Ghosh</creatorcontrib><description>NLRC3 inhibits inflammatory responses. Neuroinflammation induces and accelerates the onset of Alzheimer’s disease (AD). This study is aimed at investigating whether NLRC3 plays a role in neuroinflammation, Aβ accumulation, and neuroprotection in AD mice. 12-month-old APP/PS1 transgenic and C57 mice were used for studies in vivo. In vitro, organotypic hippocampal slices were cultured. We found that the expression of NLRC3 was downregulated in the brain tissues of APP/PS1 mice. Mice in the APP/PS1 group had a significant attenuation of learning and memory ability compared to the control group, and the ability was improved in APP/PS1 + LV-NLRC3 mice. The expressions of 6E10, GFAP, Iba1, and PI3K in the hippocampus and brains of APP/PS1 mice were significantly higher than those of the control group, while the expressions of NeuN were lower than that of the control group. With the overexpression of NLRC3 in the APP/PS1 + LV-NLRC3 group, the expressions of 6e10, GFAP, Iba1, and PI3K were significantly lower, while the expression of NeuN was significantly higher compared to the APP/PS1 group. NLRC3 colocalized with NeuN. PI3K activation with 740YP increased the expression of GFAP and Iba-1 in the hippocampus with the exogenous NLRC3 protein. We conclude that NLRC3 may play an important role in the development and progression of AD. Downregulation of NLRC3 can lead to the activation of PI3K, resulting in abnormal plaque deposition, glial cell activation, and neuron loss during AD. NLRC3 delays the progression of AD in APP/PS1 mice via inhibiting PI3K activation.</description><identifier>ISSN: 1942-0900</identifier><identifier>EISSN: 1942-0994</identifier><identifier>DOI: 10.1155/2020/5328031</identifier><identifier>PMID: 33425209</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Brain ; Cytokines ; Dementia ; Inflammation ; Kinases ; Memory ; Neurons ; Older people ; Pathogenesis ; Proteins ; Transgenic animals</subject><ispartof>Oxidative medicine and cellular longevity, 2020, Vol.2020 (2020), p.1-14</ispartof><rights>Copyright © 2020 Lihuang Zha et al.</rights><rights>Copyright © 2020 Lihuang Zha et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2020 Lihuang Zha et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-973b26555e3e0a7d0de29033a345eecc4cd3925a5d9a606a0560ce23749527e43</citedby><cites>FETCH-LOGICAL-c438t-973b26555e3e0a7d0de29033a345eecc4cd3925a5d9a606a0560ce23749527e43</cites><orcidid>0000-0002-4176-976X ; 0000-0002-8024-4501</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775163/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775163/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,27923,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33425209$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ghosh, Rajeshwary</contributor><contributor>Rajeshwary Ghosh</contributor><creatorcontrib>Guo, Wen</creatorcontrib><creatorcontrib>Zhou, Li</creatorcontrib><creatorcontrib>Fang, Jian</creatorcontrib><creatorcontrib>Yu, Zaixin</creatorcontrib><creatorcontrib>Zha, Lihuang</creatorcontrib><creatorcontrib>Zhou, Jun</creatorcontrib><title>NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation</title><title>Oxidative medicine and cellular longevity</title><addtitle>Oxid Med Cell Longev</addtitle><description>NLRC3 inhibits inflammatory responses. Neuroinflammation induces and accelerates the onset of Alzheimer’s disease (AD). This study is aimed at investigating whether NLRC3 plays a role in neuroinflammation, Aβ accumulation, and neuroprotection in AD mice. 12-month-old APP/PS1 transgenic and C57 mice were used for studies in vivo. In vitro, organotypic hippocampal slices were cultured. We found that the expression of NLRC3 was downregulated in the brain tissues of APP/PS1 mice. Mice in the APP/PS1 group had a significant attenuation of learning and memory ability compared to the control group, and the ability was improved in APP/PS1 + LV-NLRC3 mice. The expressions of 6E10, GFAP, Iba1, and PI3K in the hippocampus and brains of APP/PS1 mice were significantly higher than those of the control group, while the expressions of NeuN were lower than that of the control group. With the overexpression of NLRC3 in the APP/PS1 + LV-NLRC3 group, the expressions of 6e10, GFAP, Iba1, and PI3K were significantly lower, while the expression of NeuN was significantly higher compared to the APP/PS1 group. NLRC3 colocalized with NeuN. PI3K activation with 740YP increased the expression of GFAP and Iba-1 in the hippocampus with the exogenous NLRC3 protein. We conclude that NLRC3 may play an important role in the development and progression of AD. Downregulation of NLRC3 can lead to the activation of PI3K, resulting in abnormal plaque deposition, glial cell activation, and neuron loss during AD. NLRC3 delays the progression of AD in APP/PS1 mice via inhibiting PI3K activation.</description><subject>Brain</subject><subject>Cytokines</subject><subject>Dementia</subject><subject>Inflammation</subject><subject>Kinases</subject><subject>Memory</subject><subject>Neurons</subject><subject>Older people</subject><subject>Pathogenesis</subject><subject>Proteins</subject><subject>Transgenic animals</subject><issn>1942-0900</issn><issn>1942-0994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkc1PGzEQxa2qVaGhN86VJY40ZOyxd-NLpSh8RQ2w0HK2HO8kMQq7YG-C-O9ZlDTAracZaX7z5mkeY_sCjoTQuidBQk-j7AOKT2xXGCW7YIz6vO0Bdti3lO4AMpRKfGU7iEpqCWaXXV-Ob4bIj2nhnhNv5sSLWM8ipRTqitdTPjjmoeKDougVfwS_CJ74Kjg-quZhEppQzXgxwt984Juwck27tMe-TN0i0fdN7bDb05O_w_Pu-OpsNByMu15hv-maHCcy01oTEri8hJKkAUSHShN5r3yJRmqnS-MyyBzoDDxJzJXRMieFHfZrrfuwnNxT6alqolvYhxjuXXy2tQv246QKczurVzbPcy0ybAUONgKxflxSauxdvYxV69lKlau-6ovWZIf9XFM-1ilFmm4vCLCvAdjXAOwmgBb_8d7VFv738RY4XAPzUJXuKfynHLUMTd0bLaH1h_gCi5iULg</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Guo, Wen</creator><creator>Zhou, Li</creator><creator>Fang, Jian</creator><creator>Yu, Zaixin</creator><creator>Zha, Lihuang</creator><creator>Zhou, Jun</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4176-976X</orcidid><orcidid>https://orcid.org/0000-0002-8024-4501</orcidid></search><sort><creationdate>2020</creationdate><title>NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation</title><author>Guo, Wen ; Zhou, Li ; Fang, Jian ; Yu, Zaixin ; Zha, Lihuang ; Zhou, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-973b26555e3e0a7d0de29033a345eecc4cd3925a5d9a606a0560ce23749527e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Brain</topic><topic>Cytokines</topic><topic>Dementia</topic><topic>Inflammation</topic><topic>Kinases</topic><topic>Memory</topic><topic>Neurons</topic><topic>Older people</topic><topic>Pathogenesis</topic><topic>Proteins</topic><topic>Transgenic animals</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guo, Wen</creatorcontrib><creatorcontrib>Zhou, Li</creatorcontrib><creatorcontrib>Fang, Jian</creatorcontrib><creatorcontrib>Yu, Zaixin</creatorcontrib><creatorcontrib>Zha, Lihuang</creatorcontrib><creatorcontrib>Zhou, Jun</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oxidative medicine and cellular longevity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guo, Wen</au><au>Zhou, Li</au><au>Fang, Jian</au><au>Yu, Zaixin</au><au>Zha, Lihuang</au><au>Zhou, Jun</au><au>Ghosh, Rajeshwary</au><au>Rajeshwary Ghosh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation</atitle><jtitle>Oxidative medicine and cellular longevity</jtitle><addtitle>Oxid Med Cell Longev</addtitle><date>2020</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>14</epage><pages>1-14</pages><issn>1942-0900</issn><eissn>1942-0994</eissn><abstract>NLRC3 inhibits inflammatory responses. Neuroinflammation induces and accelerates the onset of Alzheimer’s disease (AD). This study is aimed at investigating whether NLRC3 plays a role in neuroinflammation, Aβ accumulation, and neuroprotection in AD mice. 12-month-old APP/PS1 transgenic and C57 mice were used for studies in vivo. In vitro, organotypic hippocampal slices were cultured. We found that the expression of NLRC3 was downregulated in the brain tissues of APP/PS1 mice. Mice in the APP/PS1 group had a significant attenuation of learning and memory ability compared to the control group, and the ability was improved in APP/PS1 + LV-NLRC3 mice. The expressions of 6E10, GFAP, Iba1, and PI3K in the hippocampus and brains of APP/PS1 mice were significantly higher than those of the control group, while the expressions of NeuN were lower than that of the control group. With the overexpression of NLRC3 in the APP/PS1 + LV-NLRC3 group, the expressions of 6e10, GFAP, Iba1, and PI3K were significantly lower, while the expression of NeuN was significantly higher compared to the APP/PS1 group. NLRC3 colocalized with NeuN. PI3K activation with 740YP increased the expression of GFAP and Iba-1 in the hippocampus with the exogenous NLRC3 protein. We conclude that NLRC3 may play an important role in the development and progression of AD. Downregulation of NLRC3 can lead to the activation of PI3K, resulting in abnormal plaque deposition, glial cell activation, and neuron loss during AD. NLRC3 delays the progression of AD in APP/PS1 mice via inhibiting PI3K activation.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>33425209</pmid><doi>10.1155/2020/5328031</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-4176-976X</orcidid><orcidid>https://orcid.org/0000-0002-8024-4501</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1942-0900 |
| ispartof | Oxidative medicine and cellular longevity, 2020, Vol.2020 (2020), p.1-14 |
| issn | 1942-0900 1942-0994 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7775163 |
| source | PubMed Central Open Access; Wiley Online Library Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Brain Cytokines Dementia Inflammation Kinases Memory Neurons Older people Pathogenesis Proteins Transgenic animals |
| title | NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T15%3A23%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NLRC3%20Delays%20the%20Progression%20of%20AD%20in%20APP/PS1%20Mice%20via%20Inhibiting%20PI3K%20Activation&rft.jtitle=Oxidative%20medicine%20and%20cellular%20longevity&rft.au=Guo,%20Wen&rft.date=2020&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=14&rft.pages=1-14&rft.issn=1942-0900&rft.eissn=1942-0994&rft_id=info:doi/10.1155/2020/5328031&rft_dat=%3Cproquest_pubme%3E2474848197%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2474848197&rft_id=info:pmid/33425209&rfr_iscdi=true |